Study: Sharma 2018, Journal of Alternative and Complementary Medicine

Efficacy and Safety of Ashwagandha Root Extract in Subclinical Hypothyroid Patients: A Double-Blind, Randomized Placebo-Controlled Trial

Citation

Sharma AK, Basu I, Singh S (2018). Journal of Alternative and Complementary Medicine. PubMed id 28829155.

Open on PubMed

Cards that cite this study (1)

Each card gives its own wording for who was tested, how and what was found.

  • Ashwagandha: stress, sleep, thyroid and liver cautions Tier B moderate

    B Adults aged 18 to 50 with subclinical hypothyroidism (raised TSH), one hospital in Varanasi, India (n=50)

    Randomised, double-blind, placebo-controlled pilot of ashwagandha root extract 600 mg a day for 8 weeks.

    TSH, T3 and T4 improved compared with placebo over 8 weeks. Four people withdrew (two from each group).

    As recorded in this card: Sharma AK, Basu I, Singh S (2018), Journal of Alternative and Complementary Medicine, [primary]

    Note: A small pilot at one site. NCCIH still advises people with thyroid disorders not to use ashwagandha, so this does not settle it; the two sources disagree in tone.

This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.